Diabetes Research and Clinical Practice
Volume 88, Issue 1 , Pages 7-13, April 2010

Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America☆

  • Juan J. Gagliardino

      Affiliations

    • Center of Experimental and Applied Endocrinology (CENEXA, National University of La Plata-National Research Council of La Plata), PAHO/WHO Collaborating Center for Diabetes Research, Education, and Care, La Plata, Argentina
    • Corresponding Author InformationCorresponding author at: CENEXA (UNLP-CONICET LA PLATA), Facultad de Ciencias Médicas, UNLP - Calles 60 y 120, 1900 La Plata, Argentina. Tel.: +54 221 4236712; fax: +54 221 4222081.
    • ,
  • Line Kleinebreil

      Affiliations

    • Georges Pompidou Hospital, Paris, France
    • ,
  • Stephen Colagiuri

      Affiliations

    • Department of Endocrinology, Diabetes and Metabolism, Prince of Wales Hospital, Randwick, NSW, Australia
    • ,
  • Jeff Flack

      Affiliations

    • Department of Endocrinology, Diabetes and Metabolism, Prince of Wales Hospital, Randwick, NSW, Australia
    • ,
  • Joaquín E. Caporale

      Affiliations

    • Center of Experimental and Applied Endocrinology (CENEXA, National University of La Plata-National Research Council of La Plata), PAHO/WHO Collaborating Center for Diabetes Research, Education, and Care, La Plata, Argentina
    • ,
  • Fernando Siri

      Affiliations

    • Center of Experimental and Applied Endocrinology (CENEXA, National University of La Plata-National Research Council of La Plata), PAHO/WHO Collaborating Center for Diabetes Research, Education, and Care, La Plata, Argentina
    • ,
  • Charles Clark Jr.

      Affiliations

    • Indiana University School of Medicine, Division of Continuing Medical Education, Indianapolis, USA
    • This manuscript was prepared by above authors on behalf of the ANDIAB, the DIABCARE and the QUALIDIAB Net participating centers.

Received 22 June 2009; received in revised form 17 December 2009; accepted 22 December 2009. published online 15 February 2010.

Abstract 

Aim

To compare clinical-metabolic monitoring and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.

Methods

Retrospective analysis of data collected at primary care (4540 participants from each population) matched for age, gender and disease duration. Measurements included participants’ characteristics, performance frequency of clinical-metabolic process indicators, and percentage of clinical-metabolic outcomes at recommended target values.

Results

The weighted mean of the percentage of process performance was within 68 to 81%; that of outcomes at target dropped to 29 to 45%. Although statistically significant, differences among groups were far from those in healthcare budgets, and probably only of marginal clinical impact. The percentage of patients with low, slight or high coronary risk was similar in the three groups, with most people at high or very high risk.

Conclusions

Despite the high difference in health per capita investment and system characteristics among countries, the study populations had striking similarities regarding the low percentage of participants who achieved cardiovascular risk factor and diabetes treatment goals. Therefore, differences in health budget and system characteristics would not be the main drivers in care quality. Diabetes education at every level and quality care registries would contribute to improve this situation and assess such improvement.

Keywords: Diabetes mellitus, Health care quality, Access and evaluation, Risk factors, Risk assessment, Monitoring

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ Source of financial support: The QUALIDIAB project was sponsored by the Declaration of the Americas (DOTA), with funds from Becton Dickinson and Company, Eli Lilly and Company, LifeScan Inc, Novo Nordisk A/S, and Roche Diagnostics. ANDIAB was supported by Servier Laboratories and the Australian Government Department of Health and Ageing.

PII: S0168-8227(09)00549-X

doi:10.1016/j.diabres.2009.12.024

Refers to erratum:

  • Erratum to “Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America” [Diabetes Research and Clinical Practice 2010;88:7–13] , 12 July 2010

    Juan J. Gagliardino, Line Kleinebreil, Stephen Colagiuri, Jeff Flack, Joaquín E. Caporale, Fernando Siri, Charles Clark
    Diabetes Research and Clinical Practice October 2010 (Vol. 90, Issue 1, Page 127)

Diabetes Research and Clinical Practice
Volume 88, Issue 1 , Pages 7-13, April 2010

Article Tools